These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

419 related items for PubMed ID: 15715653

  • 1. Monoamine transporter inhibitors and norepinephrine reduce dopamine-dependent iron toxicity in cells derived from the substantia nigra.
    Paris I, Martinez-Alvarado P, Perez-Pastene C, Vieira MN, Olea-Azar C, Raisman-Vozari R, Cardenas S, Graumann R, Caviedes P, Segura-Aguilar J.
    J Neurochem; 2005 Mar; 92(5):1021-32. PubMed ID: 15715653
    [Abstract] [Full Text] [Related]

  • 2. Dopamine-dependent iron toxicity in cells derived from rat hypothalamus.
    Paris I, Martinez-Alvarado P, Cárdenas S, Perez-Pastene C, Graumann R, Fuentes P, Olea-Azar C, Caviedes P, Segura-Aguilar J.
    Chem Res Toxicol; 2005 Mar; 18(3):415-9. PubMed ID: 15777081
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of VMAT-2 and DT-diaphorase induce cell death in a substantia nigra-derived cell line--an experimental cell model for dopamine toxicity studies.
    Fuentes P, Paris I, Nassif M, Caviedes P, Segura-Aguilar J.
    Chem Res Toxicol; 2007 May; 20(5):776-83. PubMed ID: 17425337
    [Abstract] [Full Text] [Related]

  • 4. Effects of 6-hydroxydopamine on primary cultures of substantia nigra: specific damage to dopamine neurons and the impact of glial cell line-derived neurotrophic factor.
    Ding YM, Jaumotte JD, Signore AP, Zigmond MJ.
    J Neurochem; 2004 May; 89(3):776-87. PubMed ID: 15086533
    [Abstract] [Full Text] [Related]

  • 5. Copper neurotoxicity is dependent on dopamine-mediated copper uptake and one-electron reduction of aminochrome in a rat substantia nigra neuronal cell line.
    Paris I, Dagnino-Subiabre A, Marcelain K, Bennett LB, Caviedes P, Caviedes R, Azar CO, Segura-Aguilar J.
    J Neurochem; 2001 Apr; 77(2):519-29. PubMed ID: 11299314
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Evaluation of metaiodobenzylguanidine uptake by the norepinephrine, dopamine and serotonin transporters.
    Glowniak JV, Kilty JE, Amara SG, Hoffman BJ, Turner FE.
    J Nucl Med; 1993 Jul; 34(7):1140-6. PubMed ID: 8315492
    [Abstract] [Full Text] [Related]

  • 11. On the neurotoxicity mechanism of leukoaminochrome o-semiquinone radical derived from dopamine oxidation: mitochondria damage, necrosis, and hydroxyl radical formation.
    Arriagada C, Paris I, Sanchez de las Matas MJ, Martinez-Alvarado P, Cardenas S, Castañeda P, Graumann R, Perez-Pastene C, Olea-Azar C, Couve E, Herrero MT, Caviedes P, Segura-Aguilar J.
    Neurobiol Dis; 2004 Jul; 16(2):468-77. PubMed ID: 15193303
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Structure-activity relationships at monoamine transporters for a series of N-substituted 3alpha-(bis[4-fluorophenyl]methoxy)tropanes: comparative molecular field analysis, synthesis, and pharmacological evaluation.
    Kulkarni SS, Grundt P, Kopajtic T, Katz JL, Newman AH.
    J Med Chem; 2004 Jun 17; 47(13):3388-98. PubMed ID: 15189035
    [Abstract] [Full Text] [Related]

  • 14. Biaryl analogues of conformationally constrained tricyclic tropanes as potent and selective norepinephrine reuptake inhibitors: synthesis and evaluation of their uptake inhibition at monoamine transporter sites.
    Zhou J, Zhang A, Kläss T, Johnson KM, Wang CZ, Ye YP, Kozikowski AP.
    J Med Chem; 2003 May 08; 46(10):1997-2007. PubMed ID: 12723962
    [Abstract] [Full Text] [Related]

  • 15. Inhibitory effect of nitric oxide on dopamine transporters: interneuronal communication without receptors.
    Kiss JP, Zsilla G, Vizi ES.
    Neurochem Int; 2004 Sep 08; 45(4):485-9. PubMed ID: 15186914
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Neurochemical characterization of the release and uptake of dopamine in ventral tegmental area and serotonin in substantia nigra of the mouse.
    John CE, Budygin EA, Mateo Y, Jones SR.
    J Neurochem; 2006 Jan 08; 96(1):267-82. PubMed ID: 16300629
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.